Question 1

What is Stop Dying Early?

Accepted Answer

Stop Dying Early is a preventive cardiovascular education platform for men 35–55, founded and run by Dr. Job Mogire, MD, FACP, FACC, a board-certified cardiologist in active clinical practice. The platform exists to close the gap between what cardiovascular medicine knows about preventing premature cardiac death in men and what most men are told about it in the 13-minute annual physical appointment. The central thesis: approximately fifty percent of men who die of coronary artery disease have no

Question 2

How is SDE different from other men's health platforms?

Accepted Answer

Three structural differences distinguish SDE from every other men's health platform currently operating: first, a practicing board-certified cardiologist (FACC) as the sole clinical author, not a PhD, not a fitness trainer, not a nurse practitioner, not a physician who left clinical practice; second, active cardiac critical care practice providing the reality-testing layer for every piece of content, the patients who did not get prevention become the cases in the ICU, which concentrates the clin

Question 3

Is the content on SDE a substitute for seeing a doctor?

Accepted Answer

No. SDE content is educational: it explains mechanisms, rates evidence, identifies gaps in standard-of-care practice, and gives you the vocabulary for better clinical conversations. It is not a substitute for in-person physician examination, diagnostic testing, or the clinical judgment that requires seeing a patient, not just reading their labs. The specific clinical boundary: SDE content teaches you what questions to ask. Your physician answers them for your specific body. The informed patient

Question 4

How does the SDE Honesty Scale work?

Accepted Answer

The SDE Honesty Scale is a five-level evidence quality rating applied to every empirical claim in SDE content. The scale is designed for the standard that governs clinical cardiology decisions, where being wrong can be irreversible. Solid (1): robust and consistent evidence from large RCTs or multiple well-designed prospective cohort studies with cardiovascular outcomes. Promising (2): good evidence with some uncertainty, typically cohort data, mechanistic studies, or smaller RCTs with surrogate

Question 5

How often is SDE content updated?

Accepted Answer

The deep dive library and Q&A Hub are reviewed and updated when significant new evidence changes the clinical guidance. The cardiovascular pharmacology space moves quickly: the SELECT trial (2023), the colchicine LoDoCo2 approval (2023), ongoing GLP-1 trials, and the expected results from tirzepatide cardiovascular outcomes studies will each require content updates as results arrive. Honesty Scale ratings are the most likely elements to update, a claim rated Early (3) when this Hub was written m

Question 6

Who is the SDE audience specifically?

Accepted Answer

Men 35–55 who are already engaged with their health, already tracking some metrics, already doing something right, and who suspect that the clinical system is not telling them the whole story. The forum quote that captures the avatar: "I'm doing everything right and my HRV keeps declining." Or: "My annual physical says I'm fine and I don't believe it." Or: "My CGM data looks perfect and my cardiologist has never mentioned ApoB." The secondary audience: Black men and African diaspora men for whom

Question 7

Why does Dr. Mogire write about trust and conflicts of interest so explicitly?

Accepted Answer

Because the men who need this information have been given bad information by sources they trusted. The Peter Attia situation is not a minor footnote, he was the primary cardiovascular longevity voice for several million men, and his trustworthiness has been materially compromised by findings he has not publicly addressed. Casey Means was nominated for Surgeon General while receiving undisclosed supplement payments. David Sinclair, whose resveratrol research underpinned a significant portion of t

Question 8

What is the Stop Dying Early deep dive library?

Accepted Answer

Twenty-six long-form clinical deep dives covering the same topics as this Q&A Hub, at greater depth. Each deep dive is 3,000–6,000 words and includes: an opening clinical scene that grounds the mechanism in a real patient encounter, a plain-English mechanism section, the Honesty Scale applied to all major claims, a counter-positioning of the major voices in the space, a cardiologist's note, a "what to do this week" section, and a featured snippet block for readers who want the direct answer with

Question 9

How should I use the Q&A Hub alongside my physician?

Accepted Answer

The Q&A Hub is designed to be brought to physician visits, not as a way of telling your physician what to do, but as a framework for asking better questions. The most productive use: before a cardiology or primary care appointment, identify two or three specific Q&A answers relevant to your current clinical situation. Read the mechanism. Note the Honesty Scale rating. Then bring the question to your physician: "I read that hs-CRP above 2.0 mg/L is a risk-enhancing factor under the ACC/AHA guidel

Question 10

What is Dr. Mogire's philosophy about pharmaceutical interventions in prevention?

Accepted Answer

The pharmaceutical philosophy is evidence-grounded, non-dogmatic, and individualized. Statins, antihypertensives, semaglutide, low-dose colchicine, PCSK9 inhibitors, each of these drugs has trial evidence quantifying its benefit in specific populations. The question is never "are you for or against medication?" It is: does the evidence justify this drug for this man's specific risk profile? Where Dr. Mogire departs from both the lifestyle-only and the medication-first camps: lifestyle interventi

Question 11

How can I share SDE content with a family member who is skeptical of medical advice?

Accepted Answer

The most effective sharing approach for skeptical family members: start with a specific question they already have, not with the platform. If your brother is questioning whether his "borderline" blood pressure really needs medication, share Q14.3 (blood pressure categories and cardiovascular risk). If your father is asking whether his CGM data means his heart is fine, share Q17.3. The Q&A format, a specific question with a direct answer, is more accessible than a long-form article for someone wh

Question 12

Does Dr. Mogire have a view on the Peter Attia protocols for longevity medicine?

Accepted Answer

Attia's longevity medicine framework, centenarian decathlete concept, primary prevention of the Four Horsemen (atherosclerosis, cancer, neurodegenerative disease, metabolic disease), emphasis on ApoB, CAC, VO2max, muscle mass, and blood glucose as the primary biomarker architecture, is the most coherent and clinically serious attempt to build a preventive medicine framework for men that currently exists in the consumer health space. The clinical science in Outlive is largely sound where it cites

Question 13

Where does the SDE research come from?

Accepted Answer

The SDE deep dives and Q&A Hub are grounded in the primary literature of cardiovascular medicine: the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA, JAMA Cardiology, Lancet, and the major subspecialty journals (Hypertension, European Heart Journal, Journal of the American Heart Association). All claims rated Solid (1) or Promising (2) are cited to a specific trial, cohort study, or guideline document, with the citation inline in the text rather

Question 14

Can I ask Dr. Mogire a specific question about my health?

Accepted Answer

Yes, through the Audit or Clinical Consultation format, which is the appropriate framework for physician-patient interaction in a medical context. Questions submitted through the general SDE contact form are read and some inform future Q&A Hub entries or deep dive topics, but they cannot receive individualized physician responses without the structure of a formal consultation. The Q&A Hub is the self-service version of this exchange: 400 questions covering the most common clinical questions in t

Question 15

Is there a community element to SDE?

Accepted Answer

The Vascular Clock Membership includes access to a private community of men 35–55 who are navigating the same questions this platform addresses: how to read the new cardiovascular risk evidence, how to have productive clinical conversations, how to integrate wearable data with clinical biomarkers, and how to maintain cardiovascular health in the specific professional and demographic context that SDE serves. The community is moderated and focused, it is not a general men's health forum. It is a g

Question 16

What does "Stop Dying Early" actually mean to Dr. Mogire personally?

Accepted Answer

I was born in Sengera, Kenya. I trained in medicine. I completed cardiology. I now stand at the junction where men arrive who did not get the prevention conversation they deserved, in the cardiac critical care unit, often at 2 or 3 AM, managing an event that was predictable and measurable and preventable if someone had looked at the right numbers in the right context three years earlier. Omwana baba, the father's child. Every man who dies at 51 of a preventable MI leaves children who carry that

Question 17

What are the limitations of the SDE content I should be aware of?

Accepted Answer

Four honest limitations: (1) Telemedicine geography, the Mogire Cardiac Risk Audit and Clinical Consultation are currently structured for US residents, limiting direct physician access to men outside the US. (2) Rapidly evolving evidence, the Honesty Scale ratings are accurate at time of publication. The GLP-1 and Lp(a) therapeutic spaces are moving quickly; ratings in these areas may require updating as new trial data arrives. (3) This content does not replace emergency evaluation, any symptoms

Question 18

How do I stay updated when new SDE content is published?

Accepted Answer

The most reliable way to stay updated is through the SDE email list, available at stopdyingearly.com. New deep dives, Q&A Hub updates, and Membership content releases are announced via email. The email list is not a marketing channel, it is a clinical content notification service. The frequency is calibrated to significant new evidence or new platform additions, not to a publishing calendar. The SDE YouTube channel publishes visual versions of deep dive content and clinical explainer videos on a

Question 19

Is there a way to get a simple summary of my risk rather than reading everything?

Accepted Answer

Yes: the Vascular Clock Starter Kit ($37) takes 45 minutes to read and produces a clear, specific framework for understanding your cardiovascular risk in the context of the seven core biomarkers. It is the condensed version of the clinical framework, not a substitute for the deep dives or the Q&A Hub, but a starting point that tells you what matters and why before you invest time in the depth. The Q&A Hub itself is organized to serve this purpose: the direct 1–2 sentence answer at the top of eac

Question 20

What is Dr. Mogire's long-term vision for Stop Dying Early?

Accepted Answer

The clinical vision is specific: to contribute meaningfully to reducing the premature cardiovascular mortality that kills men 35–55 at rates that the evidence base says are preventable. The operational vision is a platform that occupies the cardiovascular prevention content space for the men most at risk, men who are health-engaged but under-served by race-neutral guidance, men whose first-degree relatives have died of preventable cardiac events, men who have invested in their health through wea

General / SDE Platform